ROYAL BANK OF CANADA - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 21 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,160,000
+12788.9%
1,185,000
+11750.0%
0.00%
Q4 2022$9,00010,0000.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 20,060,000$23,311,0005.66%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 44,492,000$39,153,0001.56%
UBS OCONNOR LLC 26,000,000$23,448,000,0000.34%
Saltoro Capital, LP 750,000$678,0000.17%
AQR Arbitrage LLC 3,050,000$2,758,0000.10%
WATER ISLAND CAPITAL LLC 1,500,000$1,371,0000.08%
PALISADE CAPITAL MANAGEMENT, LP 3,448,000$3,103,0000.07%
OAKTREE CAPITAL MANAGEMENT LP 5,780,000$5,227,0000.07%
Teton Advisors, Inc. 400,000$358,0000.05%
MACQUARIE GROUP LTD 8,175,000$7,393,0000.01%
View complete list of PARATEK PHARMACEUTICALS INC shareholders